Clinical Trial Update: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation and cohort-expansion study of niraparib in combination with dostarlimab in pediatric patients with solid tumors has been terminated, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Dostarlimab (Jemperli) (dostarlimab)
• Niraparib (Zejula) (Niraparib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2026-01-21